159 related articles for article (PubMed ID: 24916715)
1. Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.
Vemula SK; Veerareddy PR; Devadasu VR
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):301-11. PubMed ID: 24916715
[TBL] [Abstract][Full Text] [Related]
2. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
Veerareddy PR; Vemula SK
J Drug Target; 2012 Sep; 20(8):703-14. PubMed ID: 22845842
[TBL] [Abstract][Full Text] [Related]
3. A Novel Approach to Flurbiprofen Pulsatile Colonic Release: Formulation and Pharmacokinetics of Double-Compression-Coated Mini-Tablets.
Vemula SK
AAPS PharmSciTech; 2015 Dec; 16(6):1465-73. PubMed ID: 26017285
[TBL] [Abstract][Full Text] [Related]
4. Colon targeted guar gum compression coated tablets of flurbiprofen: formulation, development, and pharmacokinetics.
Vemula SK; Bontha VK
Biomed Res Int; 2013; 2013():287919. PubMed ID: 24260738
[TBL] [Abstract][Full Text] [Related]
5. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
Vemula SK
Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
[TBL] [Abstract][Full Text] [Related]
6. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
Vemula SK; Veerareddy PR
Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery.
Vemula SK; Veerareddy PR; Devadasu VR
Drug Deliv Transl Res; 2014 Aug; 4(4):310-9. PubMed ID: 25787064
[TBL] [Abstract][Full Text] [Related]
8. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
9. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
[TBL] [Abstract][Full Text] [Related]
10. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
Khan MZ; Stedul HP; Kurjaković N
Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
[TBL] [Abstract][Full Text] [Related]
11. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
Patel MM; Amin AF
Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
[TBL] [Abstract][Full Text] [Related]
12. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
Khan MZ; Prebeg Z; Kurjaković N
J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
[TBL] [Abstract][Full Text] [Related]
13. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Development of Flurbiprofen Colon-Specific Eudragit Coated Matrix Tablets: Use of a Novel Crude Banana Peel Powder as a Time-Dependent Polymer.
Vemula SK; Daravath B; Gummadi SB; Repka M
AAPS PharmSciTech; 2023 Sep; 24(7):189. PubMed ID: 37726501
[TBL] [Abstract][Full Text] [Related]
15. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
16. Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.
Maity S; Sa B
AAPS PharmSciTech; 2016 Apr; 17(2):504-15. PubMed ID: 26271189
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
18. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
19. Optimization of budesonide compression-coated tablets for colonic delivery.
Yehia SA; Elshafeey AH; Sayed I; Shehata AH
AAPS PharmSciTech; 2009; 10(1):147-57. PubMed ID: 19199041
[TBL] [Abstract][Full Text] [Related]
20. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
Patel KN; Mehta TA
PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]